Firefly Neuroscience, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-19.9M | $-10.5M | $-2.6M | $-17.8M | $-1.1M | $413.4K | $-717.2K | $-51.0K |
| Depreciation & Amortization | $172.0K | $67.0K | $0 | $220.0K | $236.6K | $12.1K | $5.8K | $9.8K |
| Depreciation | $46.0K | $12.0K | $0 | — | — | — | — | — |
| Amortization | — | — | $176.2K | $1.4M | — | — | — | — |
| Stock-Based Compensation | $749.0K | $2.6M | $295.0K | $1.3M | $1.9M | $27.6K | $6.0K | $29.6K |
| Net Cash from Operating Activities | $-8.2M | $-6.2M | $-2.2M | $-6.0M | $-735.0K | $423.3K | $-917.1K | $-763.5K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $0 | $535.9K | $69.8K | $64.5K | $8.4K | $5.8K |
| Business Acquisitions | — | $62.0K | $0 | — | — | — | — | — |
| Net Cash from Investing Activities | $-2.5M | $-477.0K | $-386.0K | $-535.9K | $-9.6M | $-64.5K | $-8.4K | $-4.1K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $11.6M | $6.3M | $4.6M | $2.3M | $13.4M | $460.0K | $1.0K | — |
| Net Change in Cash | $937.0K | $-333.0K | $2.1M | $-4.2M | $3.1M | $818.7K | $-924.5K | $-767.6K |
| Free Cash Flow | — | — | $-2.2M | $-6.5M | $-804.8K | $358.7K | $-925.5K | $-769.3K |